1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Arteriosclerosis in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (27.27) | 18.7374 |
1990's | 18 (40.91) | 18.2507 |
2000's | 14 (31.82) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
John Chapman, M; Tselepis, AD | 1 |
Antonopoulou, S; Demopoulos, CA; Fragopoulou, E; Nomikos, T | 1 |
Baron, P; Camussi, G; Del Sorbo, L; Emanuelli, G; Forni, M; Lupia, E; Merlo, M; Montrucchio, G; Peasso, P; Pucci, A; Rizea-Savu, S; Silvestro, L; Zanini, C | 1 |
Angeli, V; Fisher, EA; Liu, J; Llodrá, J; Randolph, GJ; Trogan, E | 1 |
Angeli, V; Fisher, EA; Ishii, S; Llodrá, J; Randolph, GJ; Rong, JX; Satoh, K; Shimizu, T | 1 |
Ninio, E | 1 |
Azuma, J; Fujio, Y; Maeda, M; Matsuda, T; Nariai, T; Sumita, C; Yamane, M | 1 |
Dyerberg, J; Jørgensen, KA | 1 |
Evangelou, AM | 1 |
Häyry, P; Mennander, A; Paavonen, T; Räisänen, A; Ustinov, J | 1 |
Saito, H; Tamura, Y | 1 |
Henry, PD; Kerns, SA; Kugiyama, K; Mangin, EL; Nguy, JH | 1 |
Chapman, MJ; Dentan, C; Lesnik, P; Ninio, E | 1 |
McIntyre, TM; Prescott, SM; Stafforini, DM; Zimmerman, GA | 1 |
Barnathan, ES; Buck, CA; Cines, DB; Hug, BA; Konkle, BA; Loscalzo, J; McCrae, KR; McEver, RP; Pober, JS; Pollak, ES; Schmidt, AM; Schwartz, BS; Stern, DM; Wick, TM; Zimmerman, GA | 1 |
Durrington, PN; Mackness, B; Mackness, MI | 1 |
Fogarty, DG; Hasselwander, O; Maxwell, AP; McEneny, J; McMaster, D; Nicholls, DP; Young, IS | 1 |
Gerritsen, ME; Granger, DN; Horie, Y; Mori, N | 1 |
Calabrese, S; Delbello, C; Dobrina, A; Fiotti, N; Giansante, C; Guarnieri, G; Ponte, E; Zacchi, T | 1 |
Berliner, JA; Faull, KF; Leitinger, N; Shih, PT; Subbanagounder, G | 1 |
De Faire, U; Frostegârd, J; Lemne, C; Wu, R | 1 |
Ichihara, S; Imaizumi, T; Satoh, K; Yamada, Y; Yokota, M; Yoshida, H | 1 |
Caslake, MJ; Chamberlain, P; Holmes, SD; Macphee, CH; Packard, CJ; Suckling, KE | 1 |
Kaneko, H; Miwa, M; Nakamura, S; Nakamura, T; Sugatani, J; Uchiyama, T; Unno, N; Yamamoto, N | 1 |
Fukuzawa, K; Kogure, K; Sumida, T; Tokumura, A; Toujima, M | 1 |
Sachais, BS | 1 |
Chapman, MJ; Hourton, D; Ninio, E; Stengel, D | 1 |
Antonopoulou, S; Demopoulos, CA; Fragopoulou, E | 1 |
Block, LH; Bühler, FR | 1 |
Armstrong, ML; Densen, P; Heistad, DD; Lopez, JA; Mügge, A; Padgett, RC; Piegors, DJ | 1 |
Braquet, PG; Koltai, M | 1 |
Sellmayer, A; Weber, PC | 1 |
Hiramoto, M; Imaizumi, T; Kawamura, Y; Koyanagi, M; Satoh, K; Takamatsu, M; Takamatsu, S; Yoshida, H | 1 |
Armstrong, ML; Harrison, DG; Heistad, DD; Lopez, JA; Piegors, DJ | 1 |
Chambers, E; Foegh, ML; Khirabadi, BS; Nakanishi, T; Ramwell, PW | 1 |
Braquet, P; Chap, H; Feliste, R; Perret, B | 1 |
Beilin, LJ; Kendrew, PJ; Strophair, JM; Sturm, MJ; Taylor, RR; Vandongen, R | 1 |
Apprill, P; Ashton, J; Buja, LM; Campbell, WB; Raheja, S; Schmitz, JM; Tilton, G; Willerson, JT | 1 |
Arese, P; Biffignandi, P; Bussolino, F | 1 |
Dejana, E; Fuster, V; Lapetina, E; Moncada, S; Mustard, JF; Tans, G; Vargaftig, BB; Verstraete, M | 1 |
Holtz, H; Lang, A; Ostermann, G; Rühling, K; Till, U; Winkler, L | 1 |
Parthasarathy, S; Quinn, MT; Steinberg, D | 1 |
Hiramoto, M; Imaizumi, T; Kawamura, Y; Satoh, K; Takamatsu, S; Yoshida, H | 1 |
Ostermann, G; Rühling, K; Schlag, B; Till, U; Winkler, L; Zabel-Langhennig, R | 1 |
13 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Arteriosclerosis
Article | Year |
---|---|
Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Arteriosclerosis; Humans; Inflammation; Lipids; Phospholipases A; Phospholipases A2; Platelet Activating Factor | 2002 |
Phospholipid mediators in the vessel wall: involvement in atherosclerosis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Arteriosclerosis; Endothelium, Vascular; Humans; Phospholipases A2; Phospholipids; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled | 2005 |
Platelets and atherosclerosis.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Arteriosclerosis; Blood Platelets; Blood Vessels; Dietary Fats; Eicosapentaenoic Acid; Epoprostenol; Fatty Acids, Unsaturated; Hemostasis; Humans; Lipid Peroxides; Mitogens; Platelet Activating Factor; Platelet Aggregation; Thromboxanes | 1983 |
Platelet-activating factor (PAF): implications for coronary heart and vascular diseases.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Arteriosclerosis; Blood Vessels; Coronary Disease; Cytokines; Endothelium, Vascular; Humans; Phospholipases A; Platelet Activating Factor; Vascular Diseases; Vasculitis | 1994 |
[Antiatherogenic action of omega-3 polyunsaturated fatty acids].
Topics: Animals; Arteriosclerosis; Blood Pressure; Endothelium, Vascular; Epoprostenol; Fatty Acids, Omega-3; Humans; Lipids; Macrophage Activation; Monocytes; Platelet Activating Factor; Platelet Aggregation | 1993 |
Inflammation as an early component of atherosclerosis and vascular damage--a role for P-selectin and platelet-activating factor.
Topics: Arteriosclerosis; Cells, Cultured; Endothelium, Vascular; Humans; Leukocytes; Muscle, Smooth, Vascular; P-Selectin; Platelet Activating Factor; Time Factors; Vasculitis | 1996 |
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
Topics: Animals; Arteriosclerosis; Blood Cells; Blood Coagulation; Cell Adhesion; Cell Adhesion Molecules; Cell Differentiation; Cells, Cultured; Endothelial Growth Factors; Endothelins; Endothelium, Vascular; Epoprostenol; Extracellular Matrix; Female; Fibrinolysis; Fibroblast Growth Factor 2; Hemodynamics; Humans; Inflammation; Lymphokines; Male; Mice; Neovascularization, Physiologic; Nitric Oxide; Platelet Activating Factor; Pre-Eclampsia; Pregnancy; Thrombosis; Umbilical Veins; Vascular Diseases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Platelet-activating factor (PAF)-like oxidized phospholipids: relevance to atherosclerosis.
Topics: Animals; Arteriosclerosis; DNA; Humans; Lipid Peroxidation; Lipoproteins, LDL; Muscle, Smooth, Vascular; Phospholipids; Platelet Activating Factor | 2000 |
Platelet-endothelial interactions in atherosclerosis.
Topics: Antigens, CD; Apyrase; Arteriosclerosis; Blood Platelets; Carrier Proteins; Cell Adhesion; Cell Adhesion Molecules; Cell Communication; Endothelium, Vascular; Epoprostenol; Humans; Hypolipidemic Agents; Nitric Oxide; Nitric Oxide Synthase; P-Selectin; Platelet Activating Factor; Receptors, LDL; Receptors, Oxidized LDL; Scavenger Receptors, Class E; Ubiquitin-Protein Ligases | 2001 |
Involvement of PAF in atherogenesis. Brief review.
Topics: Animals; Arteriosclerosis; Humans; Platelet Activating Factor | 1992 |
Modification of the eicosanoid system and cell signalling by precursor fatty acids.
Topics: Animals; Arteriosclerosis; Calcium; Cell Division; Dietary Fats; Diglycerides; Eicosanoids; Fatty Acids, Essential; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Free Radicals; Humans; Inflammation; Interleukin-1; Membrane Lipids; Models, Biological; Nitric Oxide; Oxygen; Platelet Activating Factor; Signal Transduction; Tumor Necrosis Factor-alpha | 1991 |
Platelet-activating factor--a powerful lipid autacoid possibly involved in microangiopathy.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis; Blood Platelets; Calmodulin; Capillary Permeability; Chemical Phenomena; Chemistry; Cyclic AMP; Diabetic Angiopathies; Endothelium; Humans; Microcirculation; Neutrophils; Platelet Activating Factor; Steroids; Thrombosis | 1986 |
An overview of antiplatelet and antithrombotic drugs.
Topics: Adenosine Diphosphate; Arachidonic Acids; Arteriosclerosis; Blood Platelets; Blood Vessels; Endothelium; Epoprostenol; Erythrocyte Aggregation; Fibrinolytic Agents; Hemostasis; Humans; Phospholipases A; Phospholipids; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandins; Receptors, Prostaglandin; Receptors, Thromboxane; Thrombin; Thromboembolism; Thromboxane-A Synthase; Type C Phospholipases | 1985 |
31 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Arteriosclerosis
Article | Year |
---|---|
Structure elucidation of phenolic compounds from red/white wine with antiatherogenic properties.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Antioxidants; Arteriosclerosis; Blood Platelets; Humans; Lipoproteins, LDL; Oxidation-Reduction; Phenols; Phospholipases A; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rabbits; Thrombin; Wine | 2003 |
Intra-plaque production of platelet-activating factor correlates with neoangiogenesis in human carotid atherosclerotic lesions.
Topics: Adult; Aged; Arteriosclerosis; Carotid Artery Diseases; Female; Humans; Macrophages; Male; Middle Aged; Neovascularization, Pathologic; Platelet Activating Factor; Tumor Necrosis Factor-alpha | 2003 |
Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques.
Topics: Animals; Aorta, Thoracic; Apolipoproteins E; Arteriosclerosis; Cell Movement; Disease Progression; Endothelium, Vascular; Female; Kinetics; Lipids; Lysophospholipids; Male; Mice; Mice, Knockout; Monocytes; Platelet Activating Factor; Transplantation, Homologous | 2004 |
Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Apolipoproteins E; Arteriosclerosis; Cell Movement; Cholesterol, HDL; Dendritic Cells; Female; Humans; Hyperlipidemias; Immunohistochemistry; Lipoproteins, LDL; Lymph Nodes; Male; Mice; Mice, Transgenic; Organ Culture Techniques; Platelet Activating Factor; Receptors, LDL; Reverse Transcriptase Polymerase Chain Reaction; Skin | 2004 |
Platelet activating factor induces cytoskeletal reorganization through Rho family pathway in THP-1 macrophages.
Topics: Adenoviridae; Arteriosclerosis; beta-Galactosidase; cdc42 GTP-Binding Protein; Cell Line, Tumor; Cytoskeleton; Gene Transfer Techniques; Guanine Nucleotide Dissociation Inhibitors; Guanosine Triphosphate; Humans; Immunoblotting; Inflammation; Macrophages; Platelet Activating Factor; Pseudopodia; rac1 GTP-Binding Protein; rho GTP-Binding Proteins; rho-Specific Guanine Nucleotide Dissociation Inhibitors; rhoA GTP-Binding Protein; Time Factors; Up-Regulation | 2005 |
Effect of platelet-activating factor (PAF) receptor blockers on smooth muscle cell replication in vitro and allograft arteriosclerosis in vivo.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Autoradiography; Azepines; Cell Division; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Fibroblasts; Male; Muscle, Smooth, Vascular; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Inbred WF; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Transplantation, Homologous; Triazoles | 1993 |
Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta.
Topics: Animals; Aorta; Arteriosclerosis; Endothelium, Vascular; Lipoproteins, LDL; Lysophosphatidylcholines; Lysophospholipase; Male; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rabbits; Sphingosine; Vasodilation | 1993 |
Phagocytic activation induces formation of platelet-activating factor in human monocyte-derived macrophages and in macrophage-derived foam cells. Relevance to the inflammatory reaction in atherogenesis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Arteriosclerosis; Cells, Cultured; Foam Cells; Humans; Inflammation; Lipase; Macrophage Activation; Macrophages; Monocytes; Opsonin Proteins; Phagocytosis; Phospholipases A; Platelet Activating Factor; Zymosan | 1996 |
Lack of protection against oxidative modification of LDL by avian HDL.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Arteriosclerosis; Aryldialkylphosphatase; Birds; Cattle; Chickens; Cricetinae; Esterases; Guinea Pigs; Humans; In Vitro Techniques; Lipid Peroxidation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Models, Biological; Oxidation-Reduction; Phospholipases A; Platelet Activating Factor; Rabbits; Rats; Turkeys | 1998 |
HDL composition and HDL antioxidant capacity in patients on regular haemodialysis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Antioxidants; Arteriosclerosis; Aryldialkylphosphatase; beta Carotene; Carotenoids; Cholesterol; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Esterases; Fatty Acids; Female; Humans; Kidney Failure, Chronic; Lipid Peroxidation; Lycopene; Male; Middle Aged; Oxidation-Reduction; Phospholipases A; Phospholipids; Platelet Activating Factor; Renal Dialysis; Risk Factors; Vitamin E | 1999 |
Ischemia-reperfusion induced microvascular responses in LDL-receptor -/- mice.
Topics: Animals; Antibodies, Monoclonal; Arteriosclerosis; Cell Adhesion; Hypercholesterolemia; Intercellular Adhesion Molecule-1; Leukocytes; Leukotrienes; Male; Mice; Mice, Knockout; Microcirculation; Myocardial Ischemia; Myocardial Reperfusion Injury; Platelet Activating Factor; Receptors, LDL; Serum Albumin | 1999 |
Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.
Topics: Acute-Phase Proteins; Aged; Aged, 80 and over; Arteriosclerosis; CD11 Antigens; Cytokines; Exercise Test; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-1; Interleukin-6; Leukocyte Count; Leukocyte Elastase; Male; Middle Aged; Peripheral Vascular Diseases; Platelet Activating Factor; Receptors, Cytokine; Superoxides; Tumor Necrosis Factor-alpha | 1999 |
Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086.
Topics: Animals; Arteriosclerosis; Azepines; Cell Adhesion; Cells, Cultured; Endothelium, Vascular; Humans; Lipid Peroxidation; Mice; Monocytes; Phospholipid Ethers; Phospholipids; Platelet Activating Factor; Platelet Aggregation Inhibitors; Triazoles | 1999 |
Antibodies to platelet-activating factor are associated with borderline hypertension, early atherosclerosis and the metabolic syndrome.
Topics: Adult; Antibodies; Antibody Specificity; Arteriosclerosis; Blood Pressure; Endothelin-1; Humans; Hypertension; Immunoglobulin G; Insulin-Like Growth Factor Binding Protein 1; Lipoproteins; Male; Middle Aged; Platelet Activating Factor | 1999 |
Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Aged, 80 and over; Aging; Arteriosclerosis; Female; Genotype; Humans; Japan; Male; Middle Aged; Mutation, Missense; Phospholipases A; Platelet Activating Factor; Polymerase Chain Reaction; Risk Factors | 2000 |
Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Antibodies, Monoclonal; Arteriosclerosis; Biomarkers; Coronary Angiography; Enzyme-Linked Immunosorbent Assay; Humans; Lipids; Male; Middle Aged; Phospholipases A; Platelet Activating Factor; Platelet Activation; Prognosis; Risk Factors | 2000 |
Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in japan.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Arteriosclerosis; Female; Genotype; Humans; Japan; Male; Mutation; Phospholipases A; Platelet Activating Factor | 2000 |
Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity.
Topics: Arteriosclerosis; DNA; Down-Regulation; Humans; Lipopolysaccharides; Lipoproteins, LDL; Lysophosphatidylcholines; Macrophages; Monocytes; NF-kappa B; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 2001 |
Biologically active lipids with antiatherogenic properties from white wine and must.
Topics: Acetylation; Animals; Arteriosclerosis; Blood Platelets; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Lipids; Mass Spectrometry; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rabbits; Thrombin; Wine | 2002 |
Atherosclerosis, cell motility, calcium, and calcium-channel blockers.
Topics: Arteriosclerosis; Calcium; Calcium Channel Blockers; Cell Movement; Humans; Lipoproteins, LDL; Platelet Activating Factor; Platelet-Derived Growth Factor | 1992 |
Activation of leukocytes with complement C5a is associated with prostanoid-dependent constriction of large arteries in atherosclerotic monkeys in vivo.
Topics: Animals; Arteries; Arteriosclerosis; Azepines; Bridged Bicyclo Compounds, Heterocyclic; Complement C5a; Fatty Acids, Unsaturated; Hemodynamics; Hydrazines; Leukocytes; Lipids; Macaca fascicularis; Male; Platelet Activating Factor; Prostaglandins; Thromboxane A2; Triazoles; Vasoconstriction | 1992 |
Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Humans; Lipoproteins; Male; Middle Aged; Phospholipases; Phospholipases A; Platelet Activating Factor; Platelet Aggregation; Smoking | 1990 |
Vascular responses to leukocyte products in atherosclerotic primates.
Topics: Animals; Arteries; Arteriosclerosis; Dinoprostone; Epoprostenol; Hemodynamics; Leukocyte Count; Leukocytes; Lipids; Macaca fascicularis; Male; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; SRS-A; Vasoconstrictor Agents | 1989 |
Platelet-activating factor in organ transplant rejection.
Topics: Animals; Aorta; Arteriosclerosis; Diterpenes; Ginkgolides; Graft Rejection; Lactones; Lymphocytes; Macrophages; Male; Plant Extracts; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1989 |
Protective effect of BN 52021, a specific antagonist of platelet-activating factor (PAF-acether) against diet-induced cholesteryl ester deposition in rabbit aorta.
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Cholesterol Esters; Diet, Atherogenic; Diterpenes; Ginkgolides; Lactones; Platelet Activating Factor; Platelet Aggregation; Rabbits; Sterol Esterase; Sterol O-Acyltransferase | 1989 |
Whole blood aggregation and plasma lyso-PAF related to smoking and atherosclerosis.
Topics: Adenosine Diphosphate; Adult; Aged; Arteriosclerosis; Cell Aggregation; Collagen; Humans; Male; Middle Aged; Platelet Activating Factor; Smoking; Thromboxane B2; Vascular Diseases | 1989 |
Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic alpha-Antagonists; Animals; Arteriosclerosis; Coronary Circulation; Coronary Disease; Dogs; Hemodynamics; Imidazoles; Male; Platelet Activating Factor; Platelet Aggregation; Serotonin Antagonists; Thromboxane B2 | 1985 |
The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients.
Topics: Apolipoproteins; Arteriosclerosis; Biomarkers; Humans; Lipids; Male; Myocardial Infarction; Platelet Activating Factor; Platelet Function Tests; Predictive Value of Tests | 1988 |
Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.
Topics: Animals; Arteriosclerosis; Chemotaxis, Leukocyte; Foam Cells; Humans; In Vitro Techniques; Lysophosphatidylcholines; Macrophages; Monocytes; Oxidation-Reduction; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rabbits; Structure-Activity Relationship | 1988 |
[Endothelial injury as an initiating factor: vascular endothelial cell injury and biosynthesis of PAF].
Topics: Arachidonic Acids; Arteriosclerosis; Endothelium, Vascular; Humans; Platelet Activating Factor; Platelet Adhesiveness | 1988 |
Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor.
Topics: Aged; Apolipoproteins; Arteriosclerosis; Cholesterol; Humans; Lipoproteins; Male; Middle Aged; Plasma; Platelet Activating Factor | 1987 |